Intermittent Imatinib for Elderly CML Patients Shows Promise

A phase II study found that an alternative imatinib treatment schedule for elderly patients with chronic myeloid leukemia (CML) could be an effective way to reduce dosing requirements of the drug.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news